提示: 手机请竖屏浏览!

Weight and Metabolic Outcomes 12 Years after Gastric Bypass

Ted D. Adams ... 心脑血管疾病 糖尿病 • 2017.09.21
• 胃旁路术对血糖控制的改善效果可否超越通过减重实现的效果 • 饮食干预和胃旁路术对糖尿病患者代谢功能的影响比较 • 重度肥胖症胃旁路手术随访12年结局 • 糖尿病患者减肥手术与强化药物疗法的5年结局比较研究 • 减重手术与传统药物对2型糖尿病疗效的比较 • 减重手术与强化药物治疗合并糖尿病的肥胖患者的比较 • 减重手术对瑞典肥胖人群2型糖尿病的预防作用









第12年随访时,随访率超过90%。与基线水平相比,手术组的校正后体重平均变化如下:第2年随访时为-45.0 kg(95%置信区间[CI],-47.2~-42.9;平均变化百分比,-35.0%),第6年随访时为-36.3 kg(95% CI,-39.0~-33.5;平均变化百分比,-28.0%),第12年为-35.0 kg(95% CI,-38.4~-31.7;平均变化百分比,-26.9%)。非手术1组第12年随访时的平均变化为-2.9 kg(95% CI,-6.9~1.0;平均变化百分比,-2.0%),非手术2组第12年随访时的平均变化为0 kg(95% CI,-3.5~3.5;平均变化百分比,-0.9%)。

手术组基线时已患2型糖尿病的患者中,2型糖尿病的缓解情况如下:第2年随访时有66例(66/88,75%)缓解,第6年随访时有54例(54/87,62%)缓解、第12年随访时有43例(43/84,51%)缓解。第12年随访时,手术组与非手术1组比较,2型糖尿病发病率比值比(OR)为0.08(95% CI,0.03~0.24;P<0.001),手术组与非手术2组比较,2型糖尿病发病率OR为0.09(95% CI,0.03~0.29;P<0.001)。与非手术1组相比,手术组的高血压和血脂异常的缓解率高且发病率低(P均小于0.05)。



研究显示,Roux-en-Y胃旁路术后,患者可长期保持体重减轻,能够有效缓解及预防2型糖尿病、高血压和血脂异常(由美国国立糖尿病、消化和肾脏疾病研究所[National Institute of Diabetes and Digestive and Kidney Diseases]等资助)。


Ted D. Adams, Ph.D., M.P.H., Lance E. Davidson, Ph.D., Sheldon E. Litwin, M.D., Jaewhan Kim, Ph.D., Ronette L. Kolotkin, Ph.D., M. Nazeem Nanjee, Ph.D., Jonathan M. Gutierrez, B.S., Sara J. Frogley, M.B.A., Anna R. Ibele, M.D., Eliot A. Brinton, M.D., Paul N. Hopkins, M.D., M.S.P.H., Rodrick McKinlay, M.D., Steven C. Simper, M.D., and Steven C. Hunt, Ph.D.
From Intermountain Live Well Center Salt Lake, Intermountain Healthcare (T.D.A.), the Division of Cardiovascular Genetics, Department of Internal Medicine (T.D.A., L.E.D., M.N.N., J.M.G., S.J.F., P.N.H., S.C.H.), Division of General Surgery, Department of Surgery (A.R.I.), and Division of Cardiovascular Medicine, Department of Internal Medicine (P.N.H.), University of Utah School of Medicine, the Department of Health, Kinesiology and Recreation, College of Health, University of Utah (J.K.), the Utah Foundation for Biomedical Research and Utah Lipid Center (E.A.B.), and Rocky Mountain Associated Physicians (R.M., S.C.S.), Salt Lake City, and the Department of Exercise Sciences, Brigham Young University, Provo (L.E.D.) — all in Utah; the Medical University of South Carolina and the Ralph H. Johnson Veterans Affairs Medical Center, Charleston (S.E.L.); Quality of Life Consulting, and the Department of Community and Family Medicine, Duke University Health System, Durham, NC (R.L.K.); Western Norway University of Applied Sciences, Department of Health Studies, and Førde Hospital Trust, Førde, and the Morbid Obesity Centre, Vestfold Hospital Trust, Tønsberg — all in Norway (R.L.K.); and the Department of Genetic Medicine, Weill Cornell Medicine, Doha, Qatar (S.J.F., S.C.H.). Address reprint requests to Dr. Adams at Intermountain Live Well Center Salt Lake, 389 S. 900 E., Salt Lake City, UT 84102, or at ted.adams@imail.org.



1. Kremen AJ, Linner JH, Nelson CH. An experimental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg 1954;140:439-448

2. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes — 5-year outcomes. N Engl J Med 2017;376:641-651

3. Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008;299:316-323

4. Liang Z, Wu Q, Chen B, Yu P, Zhao H, Ouyang X. Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial. Diabetes Res Clin Pract 2013;101:50-56

5. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 2015;386:964-973

6. Halperin F, Ding SA, Simonson DC, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg 2014;149:716-726

7. Courcoulas AP, Belle SH, Neiberg RH, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surg 2015;150:931-940

8. Ikramuddin S, Billington CJ, Lee WJ, et al. Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial. Lancet Diabetes Endocrinol 2015;3:413-422

9. Williams RR, Hunt SC, Barlow GK, et al. Health family trees: a tool for finding and helping young family members of coronary and cancer prone pedigrees in Texas and Utah. Am J Public Health 1988;78:1283-1286

10. Adams TD, Avelar E, Cloward T, et al. Design and rationale of the Utah obesity study: a study to assess morbidity following gastric bypass surgery. Contemp Clin Trials 2005;26:534-551

11. Adams TD, Davidson LE, Litwin SE, et al. Health benefits of gastric bypass surgery after 6 years. JAMA 2012;308:1122-1131

12. Adams TD, Pendleton RC, Strong MB, et al. Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obese. Obesity (Silver Spring) 2010;18:121-130

13. Smith SC, Edwards CB, Goodman GN, Halversen RC, Simper SC. Open vs laparoscopic Roux-en-Y gastric bypass: comparison of operative morbidity and mortality. Obes Surg 2004;14:73-76

14. Horm J. Assignment of probabilistic scores to National Death Index record matches. In: Bildgrad R, ed. National Death Index Plus: coded causes of death. Hyattsville, MD: Division of Vital Statistics, National Center for Health Statistics, 1996:A5-A12.

15. Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial — a prospective controlled intervention study of bariatric surgery. J Intern Med 2013;273:219-234

16. Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA 2012;307:56-65

17. Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 2014;311:2297-2304

18. Sjöström L, Lindroos A-K, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-2693

19. Maciejewski ML, Arterburn DE, Van Scoyoc L, et al. Bariatric surgery and long-term durability of weight loss. JAMA Surg 2016;151:1046-1055

20. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122:248-256.e5

21. Aminian A, Brethauer SA, Andalib A, et al. Can sleeve gastrectomy “cure” diabetes? Long-term metabolic effects of sleeve gastrectomy in patients with type 2 diabetes. Ann Surg 2016;264:674-681

22. Carlsson LMS, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 2012;367:695-704

23. Arterburn DE, Bogart A, Sherwood NE, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg 2013;23:93-102

24. Vest AR, Heneghan HM, Agarwal S, Schauer PR, Young JB. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart 2012;98:1763-1777

25. Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 2013;347:f5934-f5934

26. Iaconelli A, Panunzi S, De Gaetano A, et al. Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up. Diabetes Care 2011;34:561-567

27. Purnell JQ, Selzer F, Wahed AS, et al. Type 2 diabetes remission rates after laparoscopic gastric bypass and gastric banding: results of the Longitudinal Assessment of Bariatric Surgery Study. Diabetes Care 2016;39:1101-1107

28. Peterhänsel C, Petroff D, Klinitzke G, Kersting A, Wagner B. Risk of completed suicide after bariatric surgery: a systematic review. Obes Rev 2013;14:369-382

29. Tindle HA, Omalu B, Courcoulas A, Marcus M, Hammers J, Kuller LH. Risk of suicide after long-term follow-up from bariatric surgery. Am J Med 2010;123:1036-1042

30. Bhatti JA, Nathens AB, Thiruchelvam D, Grantcharov T, Goldstein BI, Redelmeier DA. Self-harm emergencies after bariatric surgery: a population-based cohort study. JAMA Surg 2016;151:226-232

31. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007;357:753-761

32. Davidson LE, Adams TD, Kim J, et al. Association of patient age at gastric bypass surgery with long-term all-cause and cause-specific mortality. JAMA Surg 2016;151:631-637

33. Mitchell JE, Crosby R, de Zwaan M, et al. Possible risk factors for increased suicide following bariatric surgery. Obesity (Silver Spring) 2013;21:665-672

34. Hamad GG, Helsel JC, Perel JM, et al. The effect of gastric bypass on the pharmacokinetics of serotonin reuptake inhibitors. Am J Psychiatry 2012;169:256-263

35. Mitchell JE, King WC, Courcoulas A, et al. Eating behavior and eating disorders in adults before bariatric surgery. Int J Eat Disord 2015;48:215-222

36. Dixon JB. Self-harm and suicide after bariatric surgery: time for action. Lancet Diabetes Endocrinol 2016;4:199-200

37. Backman O, Stockeld D, Rasmussen F, Näslund E, Marsk R. Alcohol and substance abuse, depression and suicide attempts after Roux-en-Y gastric bypass surgery. Br J Surg 2016;103:1336-1342

38. Lagerros YT, Brandt L, Hedberg J, Sundbom M, Bodén R. Suicide, self-harm, and depression after gastric bypass surgery: a nationwide cohort study. Ann Surg 2017;265:235-243

39. Morgan DJ, Ho KM. Incidence and risk factors for deliberate self-harm, mental illness, and suicide following bariatric surgery: a state-wide population-based linked-data cohort study. Ann Surg 2017;265:244-252

40. Courcoulas A. Who, why, and how? Suicide and harmful behaviors after bariatric surgery. Ann Surg 2017;265:253-254

服务条款 | 隐私政策 | 联系我们